Filter
1695
Filtered Results: 1695
Text search:
Democratic
Republic
of
Congo
Featured
Recommendations
153
New Publications
624
Language
Document type
No document type
1014
Studies & Reports
348
Guidelines
97
Strategic & Response Plan
67
Manuals
55
Situation Updates
40
Fact sheets
32
Infographics
12
Training Material
11
Videos
8
Resource Platforms
6
Online Courses
4
Brochures
1
Countries / Regions
Congo, Democratic Republic of
494
Global
118
Guinea
109
Senegal
101
Burkina Faso
94
Sierra Leone
88
Liberia
85
Mali
83
Côte d’Ivoire / Ivory Coast
76
Nigeria
69
Uganda
69
Rwanda
60
Africa
51
Chad
49
Niger
46
South Sudan
46
Ethiopia
43
Cameroon
43
Ghana
36
Zambia
33
Kenya
31
West and Central Africa
29
Central African Republic
28
Syria
24
Tanzania
21
East and Southern Africa
20
South Africa
19
Afghanistan
18
Guinea-Bissau
16
Bangladesh
14
Zimbabwe
13
Malawi
13
Myanmar / Burma
13
Yemen
13
Mozambique
12
Somalia
11
Benin
11
Pakistan
10
Madagascar
10
Togo
9
Haiti
8
Indonesia
8
Sudan
8
Burundi
8
Latin America and the Carribbean
8
Western and Central Europe
8
Colombia
7
Angola
7
Middle East and North Africa
7
Philippines
6
India
6
Lebanon
6
Germany
5
Namibia
5
Lesotho
5
South–East Asia Region
5
Palestine
5
Iraq
4
Egypt
4
Asia
4
Venezuela
4
Southern Africa
4
France
4
Nepal
3
Cambodia
3
Brazil
3
Ukraine
3
Botswana
3
Mexico
3
Congo-Brazzaville
3
Gabon
3
Jordan
2
Thailand
2
Gambia
2
China
2
Papua New Guinea
2
Eswatini/ Swaziland
2
Greece
2
Iran
2
Jamaica
2
Morocco
1
USA
1
Saudi Arabia
1
Vanuatu
1
Peru
1
Switzerland
1
Ecuador
1
Libya
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Eastern Europe
1
North Korea
1
Armenia
1
Mongolia
1
Canada
1
Russia
1
Vietnam
1
North America
1
Turkmenistan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
567
Clinical Guidelines
122
Women & Child Health
90
Key Resources
83
Public Health
71
Capacity Building
20
Pharmacy & Technologies
12
Annual Report MEDBOX
1
Toolboxes
Ebola
302
COVID-19
151
HIV
124
Rapid Response
94
Mental Health
67
NTDs
64
Conflict
59
TB
49
Planetary Health
49
Refugee
43
Health Financing Toolbox
36
Global Health Education
30
Disability
24
Cholera
22
Polio
21
Natural Hazards
20
Caregiver
17
Pharmacy
14
AMR
12
NCDs
8
Specific Hazards
5
South Sudan
3
Zika
3
Social Ethics
3
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important ...
In our fourth year of producing The State of Open Humanitarian Data, we can report the highest levels yet for data availability across priority humanitarian operations. These gains can be attributed...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration ... IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan will also help strengthen health systems at community level while implementing CDI wlll help scale-up interventions agalnst other NTDs to the benefit of the wider national health systems.
On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Af...
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates betw...
Laboratory diagnosis of Buruli ulcer
recommended
A manual for health care providers.
This manual provides expert guidance on the laboratory techniques and procedures used in the diagnosis of Buruli ulcer, a disease caused by Mycobacterium ulcerans. Aimed at laboratory technicians and scientists w...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment ... people infected with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
This report documents the secondary humanitarian problems and impacts of large-scale Ebola outbreak on the different humanitarian sectors, to provide a non-exhaustive plan to help future responders. A large scale Ebola outbreak, in this document, re...
The transformation of the humanitarian landscape has already made a significant impact on the operational security of INGOs and other humanitarian actors. This report serves to inform strategic poli...
Regional Network for Equity in Health in east and southern Africa (EQUINET): Disussion Paper 113
This report synthesises the learning across the full programme of work. It presents the methods used, the context and policy motivations for deve...
This report synthesises the learning across the full programme of work. It presents the methods used, the context and policy motivations for deve...
In the last five years, i.e. how old turned the Campaign “Indifesa” (Defenceless) in 2016, that was launched by Terre des Hommes in 2012, the world has become smaller. One can actually say that the derangements following the Arab Spring in 2011 reshuffled what is stable and what produces instabi...
